Results 101 to 110 of about 2,808,658 (271)

Medication Error Reporting to Improve Patient Safety [PDF]

open access: yes, 2018
In 2006, the Institute of Medicine estimated that 1.5 million preventable adverse drug events occur in healthcare facilities annually (Institute of Medicine, 2006). Each ADE adds approximately $8,750 per hospital stay (Institute of Medicine, 2006).
Madden, Dianna
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Prevalence, Types of Medication errors and Barriers to Reporting Errors by Nurses in an Educational Hospital in Kermanshah

open access: yesحیات, 2014
Background & Aim: The most common types of medical errors are medication errors. Medication errors can cause serious health problems and should be considered a threat to patients' safety.
Maryam Mirzaei   +3 more
doaj  

Frequency of and predictors for patient-reported medical and medication errors in Switzerland

open access: yesSwiss Medical Weekly, 2011
OBJECTIVES: To analyse the frequency of and identify risk factors for patient-reported medical errors in Switzerland. The joint effect of risk factors on error-reporting probability was modelled for hypothetical patients. METHODS: A representative population sample of Swiss citizens (n = 1306) was surveyed as part of the Commonwealth Fund’
openaire   +3 more sources

Translating whole‐genome doubling into precision medicine in cancer

open access: yesMolecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

More on Reporting Medical Errors

open access: yesClinical Chemistry, 2006
Crone et al. (1) present a case study with much of their discussion about aspects of reporting suspected medical errors, particularly when there is a possibility of misconduct or violation of rules. Marx (2), who described a useful taxonomy of medical errors, recommends that no blame be given except for certain situations, …
openaire   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Fiduciary duty in error reporting

open access: yesNursing Practice Today
The letter centers around a recent study published in the Nursing Practice Today, titled “Medication errors occurrence and reporting: A qualitative study of the Jordanian nurses” (1), which sheds light on the experiences of Jordanian nurses regarding ...
Yusrita Zolkefli
doaj   +1 more source

Home - About - Disclaimer - Privacy